BioSpace News Archive

Allumiqs and Prolytix form strategic partnership to accelerate drug discovery and development

Allumiqs and Prolytix, announced their long-term, strategic partnership focused on delivering collaborative and integrated solutions to help customers optimize drug development pipelines.

March 13, 2024
·
3 min read
Drug Development

Positive Feedback From the EMA and FDA on Alzprotect’s Phase 2b/3 Development Strategy for PSP

ALZPROTECT is thrilled to announce that it has received favorable feedback from both the American and European authorities regarding the regulatory path for advancing the clinical development of Ezeprogind/AZP2006 for patients with PSP.

March 13, 2024
·
2 min read
Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023

Kuros Biosciences, a leader in next-generation bone graft technologies, announced financial results for full year 2023 along with continued significant growth.

March 13, 2024
·
10 min read
Business

Faron’s Financial Statement Release January 1 to December 31, 2023

Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on tackling cancers via novel myeloid cell targeted immunotherapies, announced audited full-year financial results for January 1 to December 31, 2023 and provided an overview of recent corporate developments.

March 13, 2024
·
40 min read
Ryvu Therapeutics Summarizes 2023 Fiscal Year and Provides Corporate Update

Ryvu Therapeutics, a clinical-stage drug discovery and development company focusing on novel small-molecule therapies that address emerging targets in oncology, summarizes its 2023 fiscal year and provides a corporate update.

March 13, 2024
·
9 min read
BioCapital

Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024

Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024.

March 13, 2024
·
4 min read
Biotech Bay

Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential MedicinesOlon to support Antheia’s continued scale up and commercialization of early products

Antheia and Olon Group announced an ongoing partnership to leverage Olon’s vast fermentation infrastructure to manufacture Antheia’s early products.

March 13, 2024
·
2 min read
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)

Catalyst Pharmaceuticals, Inc. today announced the U.S. commercial launch of AGAMREE® (vamorolone) oral suspension 40 mg/mL for the treatment of Duchenne Muscular Dystrophy (“DMD”) in patients aged two years and older.

March 13, 2024
·
7 min read
Drug Development

PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®

PDS Biotechnology Corporation announced the publication of preclinical research and a patent granted by the United States Patent and Trademark Office that strengthen the foundation of the Company’s infectious disease vaccine platform Infectimune®.

March 13, 2024
·
8 min read
Business

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

Pyxis Oncology, Inc., a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced the appointment of Santhosh Palani, Ph.D., CFA, to its board of directors, effective March 12, 2024.

March 13, 2024
·
5 min read